← Human Trials & Peer-Reviewed Studies
Effects of sunlight exposure and vitamin D supplementation on vitamin D levels in postmenopausal women in rural Thailand: A randomized controlled trial.
Plain-language guide to PMID 30219459 (2018): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 52 women.
Key Facts
- PMID
- 30219459
- Journal
- Complementary therapies in medicine
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Watcharanon W et al. (7 authors)
- DOI
- 10.1016/j.ctim.2018.06.004
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
Despite the abundant sunlight in Thailand, vitamin D deficiency is common in premenopausal and postmenopausal Thai women.
Who Took Part
The abstract describes 52 women taking part.
The age groups tagged for this paper are middle-aged adults and older adults, women only.
A 12-week randomized controlled trial was conducted in 52 postmenopausal women, age 50-70 years.
The participants were randomized to either the sunlight exposure group or the sunlight exposure with vitamin D supplementation group.
How the Study Was Run
The design is described as randomized.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Serum 25(OH)D concentration and parathyroid hormone (PTH) were measured using standard assays at baseline and 12 weeks.
What Was Measured
PubMed files the paper under topics including Dietary Supplements, Postmenopause, Rural Population, Sunlight, Thailand, Vitamin D and Vitamin D Deficiency.
The authors tagged it with the keywords Postmenopausal women and Vitamin D2.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 52 women.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2018 (Complementary therapies in medicine), a journal based in Scotland.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.